Target intelligence / Profile preview

COL4A2 antisense RNA 1 (COL4A2-AS1)

Target
COL4A2-AS1
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

COL4A2 antisense RNA 1 (COL4A2-AS1) is a human long non-coding RNA located on chromosome 13, transcribed antisense to the COL4A2 coding gene[1][3]. COL4A2-AS1 is not a protein-coding gene and has no receptor/enzyme/transporter activity. It is highly expressed in several tissues including the brain, heart, and kidneys. Functionally, COL4A2-AS1 is involved in the regulation of COL4A2 (which encodes the type IV collagen alpha 2 chain), likely by acting as a molecular sponge for microRNAs such as miR-20b-5p, modulating downstream targets such as HIF1A[1][2]. Experimental evidence, particularly in colorectal cancer, shows that COL4A2-AS1 can promote cell proliferation and aerobic glycolysis, while inhibiting this lncRNA increases apoptosis and reduces glycolysis in cancer cells[2]. Its exact mechanisms and broader physiological and pathological roles are still under investigation. There are currently no known drugs targeting COL4A2-AS1, and its use as a biomarker or therapeutic target remains largely experimental.

Other names
COL4A2-AS1COL4A2 antisense RNA 1 (non-protein coding)
02

Mechanism of action

Regulation through microRNA sponging, specifically miR-20b-5p, affecting targets like hypoxia-inducible factor 1 alpha (HIF1A)

03

Biological functions

Regulation of gene expression (specifically COL4A2 expression)Modulation of cell proliferationRegulation of apoptosisRegulation of cellular differentiationActing as a competitive endogenous RNA (ceRNA)
04

Disease associations

Cancer (specifically colorectal cancer, with possible roles in others still under investigation)
05

Biomarkers

Potential biomarker for colorectal cancer progression

Beyond the preview

Go deeper on COL4A2 antisense RNA 1 (COL4A2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COL4A2 antisense RNA 1 (COL4A2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call